Luke W. Barker

409 total citations
10 papers, 308 citations indexed

About

Luke W. Barker is a scholar working on Oncology, Immunology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Luke W. Barker has authored 10 papers receiving a total of 308 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 5 papers in Immunology and 2 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Luke W. Barker's work include Immunotherapy and Immune Responses (5 papers), Cancer Immunotherapy and Biomarkers (5 papers) and CAR-T cell therapy research (2 papers). Luke W. Barker is often cited by papers focused on Immunotherapy and Immune Responses (5 papers), Cancer Immunotherapy and Biomarkers (5 papers) and CAR-T cell therapy research (2 papers). Luke W. Barker collaborates with scholars based in United States, Canada and New Zealand. Luke W. Barker's co-authors include Annie Chan, Yvonne M. Saenger, Robyn D. Gartrell, Jisu Li, Jack R. Wands, Randy Yeh, Laurent Dercle, Emanuelle M. Rizk, Fatima‐Zohra Mokrane and Samy Ammari and has published in prestigious journals such as PLoS ONE, Cancer Research and Journal of Virology.

In The Last Decade

Luke W. Barker

10 papers receiving 302 citations

Peers

Countries citing papers authored by Luke W. Barker

Since Specialization

Citations

This map shows the geographic impact of Luke W. Barker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luke W. Barker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luke W. Barker more than expected).

Fields of papers citing papers by Luke W. Barker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luke W. Barker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luke W. Barker. The network helps show where Luke W. Barker may publish in the future.

Co-authorship network of co-authors of Luke W. Barker

This figure shows the co-authorship network connecting the top 25 collaborators of Luke W. Barker. A scholar is included among the top collaborators of Luke W. Barker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luke W. Barker. Luke W. Barker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

#	Work	Indexed citations
1	Efficacy of a 3% Kānuka oil cream for the treatment of moderate-to-severe eczema: A single blind randomised vehicle-controlled trial 2022 ·EClinicalMedicine ·(unknown), (unknown), (unknown), (unknown), (unknown), Luke W. Barker, (unknown), (unknown), Angela Liu, Allie Eathorne, Mark Weatherall, Marius Rademaker, Mike Armour, Richard Beasley, Alex Semprini	7
2	Combination immunotherapy including OncoVEXmGMCSF creates a favorable tumor immune micro-environment in transgenic BRAF murine melanoma 2022 ·Cancer Immunology Immunotherapy ·Robyn D. Gartrell, Zoë Blake, Emanuelle M. Rizk, Rolando Pérez‐Lorenzo, Stuart P. Weisberg, (unknown), (unknown), Yichun Fu, (unknown), Luke W. Barker, (unknown), (unknown), (unknown), (unknown), (unknown), Francisco Lozano, Codruța Chiuzan, Basil A. Horst, Yvonne M. Saenger	4
3	Linking Transcriptomic and Imaging Data Defines Features of a Favorable Tumor Immune Microenvironment and Identifies a Combination Biomarker for Primary Melanoma 2020 ·Cancer Research ·Robyn D. Gartrell, Andrew Chen, Emanuelle M. Rizk, Douglas K. Marks, (unknown), Thomas D. Hart, Andrew M. Silverman, (unknown), (unknown), Luke W. Barker, Kimberly M. Komatsubara, Richard D. Carvajal, Basil A. Horst, Rui Chang, (unknown), Raúl Rabadán, Yvonne M. Saenger	17
4	FLT-PET At 6 Weeks Predicts Response Assessed by CT at 12 Weeks in Melanoma Patients Treated With Pembrolizumab 2020 ·Clinical Nuclear Medicine ·Randy Yeh, Megan H. Trager, Emanuelle M. Rizk, (unknown), Luke W. Barker, Richard D. Carvajal, Larisa J. Geskin, Gary K. Schwartz, Lawrence H. Schwartz, Laurent Dercle, Yvonne M. Saenger	11
5	Prognostic and Predictive Immunohistochemistry-Based Biomarkers in Cancer and Immunotherapy 2019 ·Hematology/Oncology Clinics of North America ·Emanuelle M. Rizk, Robyn D. Gartrell, Luke W. Barker, (unknown), (unknown), Darius Bordbar, Yvonne M. Saenger	26
6	Validation of Melanoma Immune Profile (MIP), a Prognostic Immune Gene Prediction Score for Stage II–III Melanoma 2019 ·Clinical Cancer Research ·Robyn D. Gartrell, Douglas K. Marks, Emanuelle M. Rizk, (unknown), Camille L. Gérard, Luke W. Barker, Yichun Fu, (unknown), Gen Li, Jiayi Ji, (unknown), Marc S. Ernstoff, Bret Taback, Sarabjot Pabla, Rui Chang, Sandra J. Lee, John J. Krolewski, Carl Morrison, Basil A. Horst, Yvonne M. Saenger	17
7	Prognostic and theranostic 18F-FDG PET biomarkers for anti-PD1 immunotherapy in metastatic melanoma: association with outcome and transcriptomics 2019 ·European Journal of Nuclear Medicine and Molecular Imaging ·Romain‐David Seban, (unknown), Aurélien Marabelle, Randy Yeh, Éric Deutsch, Samy Ammari, Antoine Moya‐Plana, Fatima‐Zohra Mokrane, Robyn D. Gartrell, (unknown), Luke W. Barker, Amélie Bigorgne, Lawrence H. Schwartz, Yvonne M. Saenger, Caroline Robert, Laurent Dercle	91
8	Emergency department impact following the introduction of an electric scooter sharing service 2019 ·Emergency Medicine Australasia ·(unknown), Luke W. Barker, Annie Chan, (unknown)	91
9	Unusual Features of Sodium Taurocholate Cotransporting Polypeptide as a Hepatitis B Virus Receptor 2016 ·Journal of Virology ·Jisu Li, (unknown), Camille Sureau, Luke W. Barker, Jack R. Wands, Shuping Tong	38
10	Identification of Tumor Antigen AF20 as Glycosylated Transferrin Receptor 1 in Complex with Heat Shock Protein 90 and/or Transporting ATPase 2016 ·PLoS ONE ·Jason M. Shapiro, Waihong Chung, Kosuke Ogawa, Luke W. Barker, Rolf I. Carlson, Jack R. Wands, Jisu Li	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact